| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| stock price global med | 0.61 | 0.2 | 6820 | 62 | 22 |
| stock | 0.5 | 0.4 | 4064 | 15 | 5 |
| price | 1.1 | 0.2 | 4657 | 41 | 5 |
| global | 0.45 | 0.6 | 2718 | 35 | 6 |
| med | 0.38 | 0.3 | 6999 | 8 | 3 |
Global Medical REIT's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.67%), BlackRock Inc. (7.25%), State Street Corp (2.82%), Nuveen Asset Management LLC (2.72%), Brown Advisory Inc. (1.90%) and Royal Bank of Canada (1.88%).
What are the 12-month price targets for Global Medical REIT (gmre)?3 brokers have issued 12-month price targets for Global Medical REIT's stock. Their GMRE share price forecasts range from $16.00 to $17.00. On average, they expect the company's share price to reach $16.50 in the next year. This suggests a possible upside of 76.1% from the stock's current price.
What is the upside for Global Medical REIT?According to analysts' consensus price target of $16.50, Global Medical REIT has a forecasted upside of 76.1% from its current price of $9.37. Global Medical REIT has only been the subject of 2 research reports in the past 90 days.
